Received Sep 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | — | — |
| SMALLMNK | SMALLPOX + MONKEYPOX (JYNNEOS) | BAVARIAN NORDIC | UNK | — | — |
Received JYNNEOS instead of HEPLISAV-B; Initial report received on 08-Aug-2025. A consumer reported that a patient (age and gender not provided) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization and then received JYNNEOS instead of HEPLISAV-B as the second dose. No medical history or concomitant medications were reported. On an unknown date, the patient received dose 1 of a hepatitis B vaccine [HEPLISAV-B (lot number, expiration date, NDC number, route, and site not available)]. On 08-Aug-2025, after receiving HEPLISAV-B, the patient presented to the pharmacy for the second dose of HEPLISAV-B. The patient asked the pharmacy technician if they had the monkey pox vaccine and received JYNNEOS intramuscularly (lot number, expiration date, and site not provided) in error. On 08-Aug-2025, approximately 1 hour after receiving JYNNEOS instead of HEPLISAV-B, the patient received a call from the pharmacy informing the patient of the pharmacy's error. No other information was available. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.